Rate this app:

More details

Add your questions or answers

Q: How to get the best score?

Q: What is your favourite trick in this game/app?

Q: What is your strategy?

AcRIS Gameplay, Trailers and Related Videos

Watch ACRIS - How to Electronically Submit Documents video.

Watch Acris - Dont Let Me Go video.

Watch What Is ACRIS in New York Real Estate? video.

Watch Acris video.

Watch How to scrape NYC ACRIS video.

Watch How to find a Property Deed in Queens or NYC video.

Watch Acris & Infra - Hyperion (Original Mix) video.

Watch Acris - The Thing (Live MMC) video.

Watch Acris & Infra - Justice (Original Mix) video.

Watch Acris video.

About the application:

You are being asked to take part in a study that is sponsored by Pfizer (the “Sponsor”). The Sponsor is providing funding to Ochsner Clinic Foundation to conduct the study. This study is being done completely remotely by using an experimental mobile application downloaded onto your mobile device. This means that you will not have to visit a study website if you select to take part in this study. Pfizer is working to better understand if there are voice features that correlate to acute respiratory disease symptoms in particular severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The data will further characterize self-reported voice and symptom profiles for acute respiratory disease; this may benefit vaccine development across a few key illness places, including influenza and respiratory syncytial virus (RSV) infection. SARS-CoV-2 is the strain of coronavirus that causes coronavirus illness 2019 (COVID-19). Influenza is commonly known as "the flu", and is an infectious illness caused by an influenza virus. RSV is common kind of virus (germ) that can cause mild to severe respiratory tract infection ranging from mild cold-like symptoms to severe lower respiratory tract illness. You are being asked to take part in this study because you are 18 years of age or older and might become sick with SARS-CoV-2, influenza and RSV infection. The purpose of this study is to learn more about the detection and monitoring of SARS-CoV-2 disease, as determined by an experimental SARS-CoV-2 RT PCR try, measure changes in voice and symptoms from well to sick using data obtained from an Electronic diary (e-diary). It is suggested to seek out medical care from your usual health care provider in the happening of a medical problem arising while you are enrolled in this study. This study collects info and will also involve certain procedures such as providing nasal swabs and taking voice recordings which are described later in this document. You will be asked to take part in the study for about 6 to 8 weeks. This study will involve voice and symptom data collection everyday for up to a maximum of 8 weeks to monitor for symptoms similar to acute respiratory disease and SARS-CoV-2 in both the well state and, could you become ill, the sick state, utilizing the e-diary on your mobile application. Once enrolled, you will begin recording symptoms and voice entry in the e-diary and a kit with two nasal swabs will be delivered to you. You will be asked to collect nasal self-swab #1 when the try kit arrives. If you become ill with fresh or increased symptoms of respiratory disease including SARS-CoV-2 symptoms, you will be asked to collect nasal self-swab #2 and return the sample for SARS-CoV-2/ Influenza/ RSV testing. If you do not develop any symptoms between swab #1 and the end of Week 6, you will collect self-swab #2 at Day 42. Testing results will be created accessible to you, if you have associated symptoms, you could contact your regular doctor if you feel you need medical care. All SARS-CoV-2 testing results will be reported to local health authorities. The study doctor will determine whether you are eligible for the study. You may experience risks or discomforts when taking part in this study. These would be specifically similar to the collection of nasal swabs and may contain pain and general discomfort. Sometimes, the nasal swab may cause the nose to bleed. This study does not involve any change in your current or future treatment and is for research purposes only. There may be no direct benefit to you from taking part, but info learned from the study may assist another people in the future.